Radiotherapy Demand and Activity in England 2006–2020

Bentzen, 2005, Towards evidence–based guidelines for radiotherapy infrastructure and staffing needs in Europe: ESTRO QUARTS project, Radiother Oncol, 75, 355, 10.1016/j.radonc.2004.12.007 Ash, 2005, Re-audit of radiotherapy waiting times (2003), Clin Oncol, 16, 387, 10.1016/j.clon.2004.06.006 Department of Health. Radiotherapy: developing a world class service for England. Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_074575 [accessed 30.10.12]. Round, 2013, The Malthus programme: developing radiotherapy demand models for breast and prostate cancer at the local, regional and national level, Clin Oncol, 25, 538, 10.1016/j.clon.2013.05.006 Delaney, 2005, The role of radiotherapy in cancer treatment: estimating optimal utilisation from a review of evidence-based clinical guidelines, Cancer, 104, 1129, 10.1002/cncr.21324 Zhang-Salomons, 2008, Estimating the lifetime utilization rate of radiotherapy in cancer patients: the multicohort current utilization table (MCUT) method, Comput Methods Programs Biomed, 92, 99, 10.1016/j.cmpb.2008.06.011 Denham, 1995, How do we bring an acceptable level of radiotherapy services to a dispersed population?, Australas Radiol, 39, 171, 10.1111/j.1440-1673.1995.tb00264.x Williams, 2009, Radiotherapy in England in 2007: modelled demand and audited activity, Clin Oncol, 21, 575, 10.1016/j.clon.2009.07.003 Möller, 2003, SBU Survey Group. A prospective survey of radiotherapy practice 2001 in Sweden, Acta Oncol, 42, 387, 10.1080/02841860310011131 Barton, 2011, Patterns of retreatment by radiotherapy, Clin Oncol, 23, 10, 10.1016/j.clon.2010.09.013 The Scottish Government. Cancer in Scotland: Radiotherapy activity planning 2011–15. Scottish Executive, Edinburgh, 2005. Available at: http://www.scotland.gov.uk/Publications/2006/01/24131719/0 [accessed 30.10.12]. Erridge, 2007, What will be the radiotherapy machine capacity required for optimal delivery of radiotherapy in Scotland in 2015?, Eur J Cancer, 43, 1802, 10.1016/j.ejca.2007.05.022 Department of Health. Radiotherapy services in England 2012. Available at: http://www.dh.gov.uk/health/2012/11/radiotherapy-2012/ [accessed 06.11.12]. Jena, 2012, The Malthus programme – a new tool for estimating radiotherapy demand at a local level, Clin Oncol, 24, 1, 10.1016/j.clon.2011.11.009 The Malthus programme. Available at: www.camradiotherapy.org.uk/malthus [accessed 02.04.13]. The Malthus programme. Available at: www.camradiotherapy.org.uk/malthus/index2.html [accessed 02.04.13]. National Cancer Services Analysis Team (NatCanSAT). Radiotherapy definitions for the care dataset for radiotherapy. Available at: http://www.natcansat.nhs.uk/rtservices/rtds/home.htm [accessed 04.04.13]. National Population Projections. Populations projections by age and sex for the United Kingdom, Great Britain and constituent countries. Series PP2 No 26. Office for National Statistics. Cancer Research UK/Association of Cancer Registries CANCERSTATS. Available at: http://info.cancerresearchuk.org/cancerstats [accessed 18.11.11]. Møller, 2007, The future burden of cancer in England: incidence and numbers of new patients in 2020, Br J Cancer, 96, 1484, 10.1038/sj.bjc.6603746 Taylor, 2011, MERCURY study group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study, Ann Surg, 253, 711, 10.1097/SLA.0b013e31820b8d52 Tyldesley, 2011, Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia, Int J Radiat Oncol Biol Phys, 79, 1507, 10.1016/j.ijrobp.2009.12.070 Kerba, 2010, Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach, Clin Oncol, 22, 801, 10.1016/j.clon.2010.07.006 Jones, 2008, Travel time to hospital and treatment for breast, colon, rectum, lung, ovary, prostate cancer, Eur J Cancer, 44, 992, 10.1016/j.ejca.2008.02.001 Williams, 2009, Geographical variation in radiotherapy services across the UK in 2007 and the effect of deprivation, Clin Oncol, 21, 431, 10.1016/j.clon.2009.05.006 Wishart, 2010, Treatment and survival in breast cancer in the Eastern Region of England, Ann Oncol, 21, 291, 10.1093/annonc/mdp301 Tyldesley, 2000, Association between age and the utilization of radiotherapy in Ontario, Int J Radiat Oncol Biol Phys, 47, 469, 10.1016/S0360-3016(00)00440-5 National Institutes of Health State-of-the-Science Conference: Role of active surveillance in the management of men with localized prostate cancer, 5–7 December 2011. Available at: http://consensus.nih.gov/2011/docs/prostate/ASPC%20Final%20Draft%20Statement.pdf [accessed 02.04.2013]. Ahmed, 2012, Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?, Lancet Oncol, 13, e509, 10.1016/S1470-2045(12)70388-1 Dearnaley, 2012, Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial, Lancet Oncol, 13, 43, 10.1016/S1470-2045(11)70293-5 Bentzen, 2008, The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet, 371, 1098, 10.1016/S0140-6736(08)60348-7 Bentzen, 2008, The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet Oncol, 9, 331, 10.1016/S1470-2045(08)70077-9 Prewett, 2012, The management of lung cancer: a UK survey of oncologists, Clin Oncol, 24, 402, 10.1016/j.clon.2012.03.005 The Royal College of Radiologists. Radiotherapy dose-fractionation. The Royal College of Radiologists, London, 2006. Available at: http://www.rcr.ac.uk/publications.aspx?PageID=149&PublicationID=229 [accessed 30.10.12].